SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-021969
Filing Date
2022-08-11
Accepted
2022-08-11 07:40:58
Documents
64
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 944439
2 ex10-3.htm EX-10.3 395741
3 ex31-1.htm EX-31.1 15451
4 ex31-2.htm EX-31.2 15197
5 ex32.htm EX-32 12516
  Complete submission text file 0001493152-22-021969.txt   5197168

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abeo-20220630.xsd EX-101.SCH 29672
7 XBRL CALCULATION FILE abeo-20220630_cal.xml EX-101.CAL 61118
8 XBRL DEFINITION FILE abeo-20220630_def.xml EX-101.DEF 151552
9 XBRL LABEL FILE abeo-20220630_lab.xml EX-101.LAB 320226
10 XBRL PRESENTATION FILE abeo-20220630_pre.xml EX-101.PRE 256230
58 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 679640
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 221153724
SIC: 2834 Pharmaceutical Preparations